Article
Comprehensive sequencing of PALB2 in patients with breast cancer suggests PALB2 mutations explain a subset of hereditary breast cancer.
Cancer - 1 Apr 2014
Fernandes Priscilla H, Saam Jennifer, Peterson Jenny, Hughes Elisha, Kaldate Rajesh, Cummings Shelly, Theisen Aaron, Chen Sonia, Trost Jeffrey, Roa Benjamin B
Abstract excerpt
BACKGROUND: This study sought to determine the prevalence of PALB2 mutations in a cohort referred for diagnostic testing for hereditary breast cancer. METHODS: Sanger sequencing was used to analyze the entire coding region and flanking introns of PALB2 in anonymized DNA samples from 1479 patients. Samples were stratified into a "high-risk" group, 955 samples from individuals predicted to have a high probability...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
